FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 310:95-102 January 12, 1984 Number 2 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

Despite the considerable literature on the overuse of new medical technologies, little attention has been paid to the biologic and monetary costs that may be incurred by underuse. Percutaneous transluminal angioplasty as a treatment for peripheral vascular disease is an example of an important technology that has been underused. Although angioplasty alone is less costly but also less efficacious than surgery, a strategy that combines the two procedures (angioplasty first, then surgery if angioplasty is unsuccessful or if occlusion recurs) is uniformly superior to surgery alone in patients who have lesions for which angioplasty can be considered. From a nationwide perspective, if 40 per cent of all patients with iliac or femoral disease (or both) requiring intervention were treated with the combined strategy, there would be an estimated savings (as compared with surgery alone) of 352 lives and $82 million, as well as an additional 5006 patent limbs. Despite these advantages, the use of angioplasty during the period under consideration (up to 1980) was limited, possibly because of the mechanism of patient triage and the inertial forces that operate when a therapeutic method that appears effective--even if more complex and hazardous than a newer approach--has been widely applied.

This article has been cited by other articles:

• Bosch, J. L., Haaring, C., Meyerovitz, M. F., Cullen, K. A., Hunink, M. G. M. (2000). Cost-Effectiveness of Percutaneous Treatment of Iliac Artery Occlusive Disease in the United States. Am. J. Roentgenol. 175: 517-521 [Abstract] [Full Text]  
• Fetterolf, D. E. (1999). A Framework for Evaluating Underutilization of Health Care Services. American Journal of Medical Quality 14: 89-97 [Abstract]  
• Danese, M. D., Powe, N. R., Sawin, C. T., Ladenson, P. W. (1996). Screening for Mild Thyroid Failure at the Periodic Health Examination: A Decision and Cost-effectiveness Analysis. JAMA 276: 285-292 [Abstract]  
• Labropoulos, N., Giannoukas, A. D., Kutoubi, A. A., Nicolaides, A. N. (1996). Pseudoaneurysm of Superficial Femoral Artery After Balloon Angioplasty: Report of Two Cases. VASC ENDOVASCULAR SURG 30: 255-259 [Abstract]  
• Hunink, M. G. M., Wong, J. B., Donaldson, M. C., Meyerovitz, M. F., de Vries, J., Harrington, D. P. (1995). Revascularization for Femoropopliteal Disease: A Decision and Cost-effectiveness Analysis. JAMA 274: 165-171 [Abstract]  
• Hunink, M. G.M., Wong, J. B., Donaldson, M. C., Meyerovitz, M. F., Harrington, D. P. (1994). Patency Results of Percutaneous and Surgical Revascularization for Femoropopliteal Arterial Disease. Med Decis Making 14: 71-81 [Abstract]  
• Miller, B. V., Sharp, W. J., Shamma, A. R., Kresowik, T. F., Petrone, S., Corson, J. D. (1991). Surveillance for Recurrent Stenosis After Endovascular Procedures: A Prospective Study. Arch Surg 126: 867-872 [Abstract]  
• Dalman, R. L., Taylor, L. M. Jr, Porter, J. M. (1990). Current Status of Extracoronary Endovascular Procedures. PERSPECT VASC SURG ENDOVASC THER 3: 1-24  
• Andros, G. (1990). Expert Commentary. PERSPECT VASC SURG ENDOVASC THER 3: 29-32  
• Widlus, D. M., Osterman, F. A. Jr (1989). Evaluation and Percutaneous Management of Atherosclerotic Peripheral Vascular Disease. JAMA 261: 3148-3154 [Abstract]  
• England, W. L., Roberts, S. D., Grim, C. E. (1987). Surgery or Angioplasty for Cost-effective Renal Revascularization?. Med Decis Making 7: 84-91 [Abstract]  
• Cambria, R. P., Faust, G., Gusberg, R., Tilson, M. D., Zucker, K. A., Modlin, I. M. (1987). Percutaneous Angioplasty for Peripheral Arterial Occlusive Disease: Correlates of Clinical Success. Arch Surg 122: 283-287 [Abstract]  
• Kwasnik, E. M., Siouffi, S. Y., Jay, M. E., Khuri, S. F. (1987). Comparative Results of Angioplasty and Aortofemoral Bypass in Patients With Symptomatic Iliac Disease. Arch Surg 122: 288-291 [Abstract]  
• KASSIRER, J. P., MOSKOWITZ, A. J., LAU, J., PAUKER, S. G. (1987). Decision Analysis: A Progress Report. ANN INTERN MED 106: 275-291 [Abstract]  
• Donabedian, A. (1986). Quality Assurance in Our Health Care System. American Journal of Medical Quality 1: 6-12  
• Freiman, D. B., Freiman, M. P., Spence, R. K., McLean, G. K., Berkowitz, H. D. (1985). Economic Impact of Transluminal Angioplasty. ANGIOLOGY 36: 772-777 [Abstract]  
• de Vries, S. O., Visser, K., de Vries, J. A., Wong, J. B., Donaldson, M. C., Hunink, M. G. M. (2002). Intermittent Claudication: Cost-effectiveness of Revascularization versus Exercise Therapy. Radiology 222: 25-36 [Abstract] [Full Text]